213 related articles for article (PubMed ID: 37478584)
1. Independent and additive contribution of white matter hyperintensities and Alzheimer's disease pathology to basal forebrain cholinergic system degeneration.
Kindler C; Upadhyay N; Bendella Z; Dorn F; Keil VC; Petzold GC
Neuroimage Clin; 2023; 39():103477. PubMed ID: 37478584
[TBL] [Abstract][Full Text] [Related]
2. Basal forebrain atrophy correlates with amyloid β burden in Alzheimer's disease.
Kerbler GM; Fripp J; Rowe CC; Villemagne VL; Salvado O; Rose S; Coulson EJ;
Neuroimage Clin; 2015; 7():105-13. PubMed ID: 25610772
[TBL] [Abstract][Full Text] [Related]
3. Age and Anterior Basal Forebrain Volume Predict the Cholinergic Deficit in Patients with Mild Cognitive Impairment due to Alzheimer's Disease.
Richter N; David LS; Grothe MJ; Teipel S; Dietlein M; Tittgemeyer M; Neumaier B; Fink GR; Onur OA; Kukolja J
J Alzheimers Dis; 2022; 86(1):425-440. PubMed ID: 35068451
[TBL] [Abstract][Full Text] [Related]
4. Cholinergic white matter pathways in dementia with Lewy bodies and Alzheimer's disease.
Schumacher J; Ray NJ; Hamilton CA; Donaghy PC; Firbank M; Roberts G; Allan L; Durcan R; Barnett N; O'Brien JT; Taylor JP; Thomas AJ
Brain; 2022 Jun; 145(5):1773-1784. PubMed ID: 34605858
[TBL] [Abstract][Full Text] [Related]
5. Basal forebrain volume reliably predicts the cortical spread of Alzheimer's degeneration.
Fernández-Cabello S; Kronbichler M; Van Dijk KRA; Goodman JA; Spreng RN; Schmitz TW;
Brain; 2020 Mar; 143(3):993-1009. PubMed ID: 32203580
[TBL] [Abstract][Full Text] [Related]
6. Measurement of basal forebrain atrophy in Alzheimer's disease using MRI.
Teipel SJ; Flatz WH; Heinsen H; Bokde AL; Schoenberg SO; Stöckel S; Dietrich O; Reiser MF; Möller HJ; Hampel H
Brain; 2005 Nov; 128(Pt 11):2626-44. PubMed ID: 16014654
[TBL] [Abstract][Full Text] [Related]
7. Antemortem basal forebrain atrophy in pure limbic TAR DNA-binding protein 43 pathology compared with pure Alzheimer pathology.
Teipel SJ; Grothe MJ;
Eur J Neurol; 2022 May; 29(5):1394-1401. PubMed ID: 35122358
[TBL] [Abstract][Full Text] [Related]
8. Atrophy of Basal Forebrain Initiates with Tau Pathology in Individuals at Risk for Alzheimer's Disease.
Cantero JL; Atienza M; Lage C; Zaborszky L; Vilaplana E; Lopez-Garcia S; Pozueta A; Rodriguez-Rodriguez E; Blesa R; Alcolea D; Lleo A; Sanchez-Juan P; Fortea J;
Cereb Cortex; 2020 Apr; 30(4):2083-2098. PubMed ID: 31799623
[TBL] [Abstract][Full Text] [Related]
9. In vivo cholinergic basal forebrain atrophy predicts cognitive decline in de novo Parkinson's disease.
Ray NJ; Bradburn S; Murgatroyd C; Toseeb U; Mir P; Kountouriotis GK; Teipel SJ; Grothe MJ
Brain; 2018 Jan; 141(1):165-176. PubMed ID: 29228203
[TBL] [Abstract][Full Text] [Related]
10. Alterations in white matter volume and its correlation with neuropsychological scales in patients with Alzheimer's disease: a DARTEL-based voxel-based morphometry study.
Moon CM; Shin IS; Jeong GW
Acta Radiol; 2017 Feb; 58(2):204-210. PubMed ID: 27081089
[TBL] [Abstract][Full Text] [Related]
11. MRI-based basal forebrain atrophy and volumetric signatures associated with limbic TDP-43 compared to Alzheimer's disease pathology.
Teipel S; Grothe MJ;
Neurobiol Dis; 2023 May; 180():106070. PubMed ID: 36898615
[TBL] [Abstract][Full Text] [Related]
12. FEOBV-PET to quantify cortical cholinergic denervation in AD: Relationship to basal forebrain volumetry.
Aghourian M; Aumont É; Grothe MJ; Soucy JP; Rosa-Neto P; Bedard MA
J Neuroimaging; 2021 Nov; 31(6):1077-1081. PubMed ID: 34462992
[TBL] [Abstract][Full Text] [Related]
13. Cholinergic white matter pathways make a stronger contribution to attention and memory in normal aging than cerebrovascular health and nucleus basalis of Meynert.
Nemy M; Cedres N; Grothe MJ; Muehlboeck JS; Lindberg O; Nedelska Z; Stepankova O; Vyslouzilova L; Eriksdotter M; Barroso J; Teipel S; Westman E; Ferreira D
Neuroimage; 2020 May; 211():116607. PubMed ID: 32035186
[TBL] [Abstract][Full Text] [Related]
14. Structural (dys)connectivity associates with cholinergic cell density in Alzheimer's disease.
Lin CP; Frigerio I; Boon BDC; Zhou Z; Rozemuller AJM; Bouwman FH; Schoonheim MM; van de Berg WDJ; Jonkman LE
Brain; 2022 Aug; 145(8):2869-2881. PubMed ID: 35259207
[TBL] [Abstract][Full Text] [Related]
15. Structural degeneration of the nucleus basalis of Meynert in mild cognitive impairment and Alzheimer's disease - Evidence from an MRI-based meta-analysis.
Mieling M; Meier H; Bunzeck N
Neurosci Biobehav Rev; 2023 Nov; 154():105393. PubMed ID: 37717861
[TBL] [Abstract][Full Text] [Related]
16. Cell loss in the nucleus basalis is related to regional cortical atrophy in Alzheimer's disease.
Cullen KM; Halliday GM; Double KL; Brooks WS; Creasey H; Broe GA
Neuroscience; 1997 Jun; 78(3):641-52. PubMed ID: 9153647
[TBL] [Abstract][Full Text] [Related]
17. Subregional volume reduction of the cholinergic forebrain in subjective cognitive decline (SCD).
Scheef L; Grothe MJ; Koppara A; Daamen M; Boecker H; Biersack H; Schild HH; Wagner M; Teipel S; Jessen F
Neuroimage Clin; 2019; 21():101612. PubMed ID: 30555006
[TBL] [Abstract][Full Text] [Related]
18. The canonical pattern of Alzheimer's disease atrophy is linked to white matter hyperintensities in normal controls, differently in normal controls compared to in AD.
Riphagen JM; Suresh MB; Salat DH;
Neurobiol Aging; 2022 Jun; 114():105-112. PubMed ID: 35414420
[TBL] [Abstract][Full Text] [Related]
19. Basal forebrain septal nuclei are enlarged in healthy subjects prior to the development of Alzheimer's disease.
Butler T; Harvey P; Deshpande A; Tanzi E; Li Y; Tsui W; Silver C; Fischer E; Wang X; Chen J; Rusinek H; Pirraglia E; Osorio RS; Glodzik L; de Leon MJ
Neurobiol Aging; 2018 May; 65():201-205. PubMed ID: 29499501
[TBL] [Abstract][Full Text] [Related]
20. Neuropathologic features associated with basal forebrain atrophy in Alzheimer disease.
Teipel SJ; Fritz HC; Grothe MJ;
Neurology; 2020 Sep; 95(10):e1301-e1311. PubMed ID: 32631924
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
